Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 35, Issue -, Pages 63-72Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2015.06.005
Keywords
-
Categories
Funding
- NIH [AI090671]
Ask authors/readers for more resources
Aptamers, nucleic acids selected for high affinity binding to proteins, can be used to activate or antagonize immune mediators or receptors in a location and cell-type specific manner and to enhance antigen presentation. They can also be linked to other molecules (other aptamers, siRNAs or miRNAs, proteins, toxins) to produce multifunctional compounds for targeted immune modulation in vivo. Aptamer-siRNA chimeras (AsiCs) that induce efficient cell-specific knockdown in immune cells in vitro and in vivo can be used as an immunological research tool or potentially as an immunomodulating therapeutic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available